baber/WOPTO huggingface dataset:
Patent FI-915506-A0 (FI)
Inventor: VAN OEVEREN JACOBUS JOHANNES
IPC: B65B43/12
Filed: 1991-11-22
Abstract: A device for filling and subsequent sealing of a capsule chain, (2) in a flat-folded state from a supply coil (1) comprising a pair of cooperating drawing rollers (8) which are mounted for rotation about vertical axes, a travelling space connected to the outlet side of said rollers and confined by the opposite runs of a pair of upright positioned endless conveyor belts (13)  filling means being provided above said space and a welding station (25) being connected to the outlet end of said travelling space, equipped with a pair of welding beams (25) positioned one opposite the other and extending in the travelling direction, perforations being provided in the outer surfaces of the drawing rollers, through which said surfaces are connected to a source of sub-atmospheric pressure at the outlet side of the roller pair, said opposite belt runs being also subjected to a source of sub-atmospheric pressure through perforations provided in supporting walls for said belt runs. According to the invention two endless belts (6) are provided between the supply coil (1) and the drawing roller pair (8) adjacent the upper edge of the capsule chain (2) said belts being positioned in a horizontal plane and mating with grooves in the circumferential surface of the respective, driven drawing rollers, the adjacent runs of said belts being adapted to clamp the upper edge of the capsule chain between them, while at the outlet end of the travelling space there is also at least one pair of endless belts positioned on either side of the path of the capsule chain in a substantially horizontal plane adjacent the upper edge of the capsule chain, said belts being guided about pulleys adapted to be driven at a speed corresponding to the drawing off speed. <IMAGE>
Patent FI-933249-A0 (FI)
Inventor: DUCHESNE JEAN-PIERRE
IPC: C07C233/87
Filed: 1993-07-16
Abstract: (2R,3S)- beta -Phenylisoserine, its salts and its preparation by the action of ammonia on (2R,3R)- beta -phenylglycidic acid, and its use for the preparation of taxane derivatives of general formula: <IMAGE> (R = H, COCH3; R1 = C6H5, (CH3)3C-O-).t
Patent FI-940981-A0 (FI)
Inventor: KESKITALO ILKKA
IPC: H04W92/00
Filed: 1994-03-01
Abstract: PCT No. PCT/FI95/00083 Sec. 371 Date Jul. 29, 1996 Sec. 102(e) Date Jul. 29, 1996 PCT Filed Feb. 17, 1995 PCT Pub. No. WO95/24771 PCT Pub. Date Sep. 14, 1995A base station equipment, mobile station and data transmission method in a digital CDMA cellular radio network, in which base stations communicate with mobile stations located in an area. Each mobile station can have a duplex connection with more than one of the base stations simultaneously. Signals transmitted from more than one of the base stations can be combined in a respective mobile station. A signal received from a mobile station in more than one of the base stations can be combined in a base station controller. In the network, traffic channel transmission is carried out by using a predetermined frame structure. Cellular network frames of different types are transmitted between respective ones of the base stations and the mobile stations over radio paths. To simplify the structure of the base station equipment, the type of frame being transmitted is indicated by a predetermined frame identifier. If the frame identifiers of the frames received simultaneously via several paths are similar, the frames are combined, but if the frame identifiers are different, the frames are not combined.
Patent FI-951249-A0 (FI)
Inventor: BERNOTAS RONALD CHARLES
IPC: A61P25/00
Filed: 1995-03-16
Abstract: The present invention is directed to a new class of 2-optionally substituted-4-piperazine-benzothiophene derivatives of the formula     <IMAGE>  Formula I  in which Y is represented by hydrogen or C1-3 alkyl; R is represented by a substituent selected from the group consisting of hydrogen, C1-4 alkyl, C1-4 alkoxy, halogen, -CF3, -OCF3, and -OH; R1 is represented by hydrogen, cycloalkyl, C1-6 alkyl, phenyl optionally substituted, phenylalkyl, or phenylamidoalkyl; X is represented by hydrogen, -(CH2)nX1, CH=CHX1 or CHX2-(CH2)q -CH3; n is an integer from 0-2; q is either the integer 0 or 1; X1 is represented by -OH-,-OR2, -NR2R3, -CO2R2, -CONR2R3, -CN, or -COR2; R2 and R3 are each independently represented by hydrogen, C1-4 alkyl, phenyl optionally substituted, phenylalkyl, or R2 and R3 together form a (CH2)m cycloalkyl, where m=2- 6; X2 is -OR4 or -NR4R5 in which R4 and R5 are each independently hydrogen or C1-4 alkyl; and the pharmaceutically acceptable addition salts thereof; with the proviso that when n is O or X is -CH=CHX1, then X1 is not OH, OR2, or NR2R3; that are serotonin 5HT1A and 5HT1D receptor agents.
Patent FI-955715-A0 (FI)
Inventor: MAITREJEAN SERGE
IPC: G01N23/06
Filed: 1995-11-27
Abstract: PCT No. PCT/FR94/00580 Sec. 371 Date Jul. 12, 1996 Sec. 102(e) Date Jul. 12, 1996 PCT Filed May 16, 1994 PCT Pub. No. WO94/28442 PCT Pub. Date Dec. 8, 1994The method comprises the following stages: first the attenuation function of at least three reference materials are determined across a wide x-ray spectrum and projection functions (Fp1, Fp2, Fp3, Fp4) forming a base are derived therefrom, then the attenuation function in said x-ray spectrum of at least one target material is determined and the attenuation function of each target material is projected onto said base; further, for each point of the object (1), the attenuation function of the object (1) is determined in said x-ray spectrum and projected onto said base, and the projections so obtained are compared with the projection from each target material and from this comparison an inference is made whether at least one target material enters the constitution of the object (1) at the point of inspection. Application: luggage inspection and control.
Patent FI-970634-A0 (FI)
Inventor: OLBRICH MATTHIAS
IPC: A61K9/48
Filed: 1997-02-14
Abstract: The invention relates to formulations of cyclosporin with high bioavailability for oral administration, which contain about 1 part by weight of one or more cyclosporin(s), preferably cyclosporin A and/or cyclosporin G, 7.5 to 7.8 parts by weight of one or more polyethylene glycol esters of saturated C10-C22hydroxy fatty acids, 0.7 to 0.85 part by weight of a monohydric alcohol as co-solvent, and 0.7 to 0.8 part by weight of a polyhydric alcohol as co-solvent. The drug form is produced by initially dissolving the cyclosporin in ethanol and, while stirring, adding propylene glycol and SOLUTOL(R) HS 15 until a clear, viscous solution results, bottled as drinkable solution or packed into capsules.
Patent FI-991088-A0 (FI)
Inventor: NIEMI VALTTERI
IPC: H04L9/32
Filed: 1999-05-11
Abstract: The invention is directed to a method for checking the integrity of messages between a mobile station and the cellular network. Two time-varying parameters are used in MAC calculation, one of which is generated by the mobile station, and the other by the network. The parameter specified by the network is used in one session only, and is transmitted to the mobile station in the beginning of the connection. The parameter specified by the mobile station is stored in the mobile station between connections in order to allow the mobile station to use a different parameter in the next connection. The parameter specified by the mobile station is transmitted to the network in the beginning of the connection.
Patent FI-991107-A0 (FI)
Inventor: RUOTTU SEPPO
IPC: C10K1/04
Filed: 1999-05-14
Abstract: The invention relates to a process and apparatus for the gasification of a carbonaceous material. According to the process, the carbonaceous material is gasified at an elevated temperature to produce gas, condensable compounds are separated from the gas, and the product gas thus obtained is recovered. According to the invention, in order to separate the condensable compounds the gas obtained from the gasifiers is directed to a dry scrubber (2) operating according to the fluidized bed priciple, wherein it is contacted with the bed material of the fluidized bed, the interior temperature of the dry scrubber being maintained lower than the condensation temperature of the condensable compounds in order to condense these compounds into the bed material. By means of the invention, a substantially tar-free gas can be produced which is suitable for the production of both heat and electricity.
Patent IL-71100-A0 (IL)
Title: Fungicidal compositions comprising 1,3-diazolyl-2-propanols,their preparation and their use
IPC: C07D249/08
Filed: 1984-02-28
Abstract: A fungicidal composition comprising a fungicidally effective amount of a 1,3-diazolyl-2-propanol of the formula   <IMAGE>   in which Alk1 is alkyl, and Alk2 is alkyl, or Alk1 and Alk2 together complete a cycloaliphatic ring, X is a nitrogen atom or the CH group, Y is a nitrogen atom or the CH group, and R is optionally substituted phenyl, phenylalkyl, phenoxy, phenylthio, phenoxyalkyl, phenylthioalkyl, benzyloxy or benzylthio, or a physiologically acceptable product thereof with an acid or metal salt in admixture with a diluent.
Patent IL-72966-A0 (IL)
Title: Process for the preparation of insulin derivatives,the b chain of which is lengthened c-terminally,novel insulin derivatives modified by bases,agents containing these derivatives and their use
IPC: C07K14/575
Filed: 1984-09-17
Abstract: 1. A process for the preparation of an insulin derivative of the formula I,   see diagramm : EP0140084,P8,F1   in which R**1 denotes H or H-Phe, a) R**30 represents the radical of a neutral, naturally occurring L-aminoacid and R**31 represents a physiologically acceptable organic group of basic character, comprising up to 3 alpha-aminoacids in which the terminal carboxyl function is in the free form, or b) R**30 represents the radical of a basic, naturally occurring L-aminoacid and R**31 represents a physiologically acceptable organic group of neutral or basic character, comprising up to 3 alpha-aminoacids in which the terminal carboxyl function is in the free from and which insuline derivative has an isoelectric point above 5.8, which comprises reacting an insulin of the formula I in which R**1 denotes H or H-Phe, R**30 denotes the radical of a genetically codable L-aminoacid and R**31 represents OH or a protective group of the carboxy function, with a peptide of the formula III in which a) R**30 represents the radical of a neutral, naturally occurring L-aminoacid and R**31 represents a physiologically acceptable organic group of basic character, comprising up to 3 alpha-aminoacids in which the terminal carboxyl function is in the free from, or b) R**30 represents the radical of a basic, naturally occurring L-aminoacid and R**31 represents a physiologically acceptable organic group of neutral or basic character, comprising up to 3 alpha-aminoacids in which the terminal carboxyl function is in the free form, in the presence of trypsin-like endopeptidase in water, if appropriate with the addition or a suitable organic solvent at a pH value below the isoelectric point of the insulin, and splitting off any protective groups introduced into the side chains.
Patent IL-76697-A0 (IL)
Title: Combinations of dihydropyridines with ace inhibitors and medicaments containing them
IPC: A61K38/55
Filed: 1985-10-14
Abstract: The invention concerns a combination of dihydropyridine derivatives with compounds which inhibit the formation of enzymes which control the conversion of angiotensin I into angiotensin II and their use as antihypertensive agents.
Patent IL-87604-A0 (IL)
Title: Pyrrolo(1,2-a)imidazole and pyrrolo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
IPC: C07D487/04
Filed: 1988-08-30
Abstract: Compounds comprising pyridyl and phenyl substituted pyrrolo[1,2-a]imidazole derivatives and pyridyl and phenyl substituted imidazo[1,2-a]pyridine derivatives, of formula   <CHEM> wherein n = 0 or 1, and their use as 5-lipoxygenase pathway inhibitors.
Patent IL-93647-A0 (IL)
Title: Impact modified medical film
IPC: B32B7/12
Filed: 1990-03-06
Abstract: An impact resistant film suitable for medical solution pouches and the packaging of parenteral meterials generally includes an interior layer of an ethylene vinyl acetate copolymer and outer layers of a propylene homopolymer or copolymer blended with a styrene ethylene butylene styrene copolymer. In some cases, a flexible copolyester may be substituted for one of the outer blend materials. Sacrificial layers may optionally be included on one or both outer surfaces of the film to improve processing.
Patent IL-99931-A0 (IL)
Title: Adjustable dose dispenser
IPC: B65D83/14
Filed: 1991-11-01
Abstract: A liquid dispensed in adjustable, predetermined quantities from a pressurized reservoir upon each actuation of a metering and dispensing valve incorporated in the dispenser. A flexible sleeve is disposed between the reservoir chamber and a selected one of a plurality of differently sized metering chambers to expel the contents of the selected metering chamber when the metering and dispensing valve is actuated. The metering chambers are carried by a rotatably adjustable member which is mounted to the stem of the metering and dispensing valve.
Patent AU-PR430201-A0 (AU)
Title: Linerbolt removing tool
IPC: B25B27/04
Filed: 2001-04-09
Abstract: A pneumatic linerbolt removing tool including a moil supported for reciprocal movement along a hammer axis within a housing, an inertial body movably mounted along the hammer axis, and a piston assembly moveable within the inertial body along the hammer axis between a striking position at which it strikes the moil and a retracted position remote therefrom. The tool further including a gas-charged accumulator for urging the piston toward the moil and air supply to a cylinder adapted to urge a biasing piston on the inertial body relative to the housing and toward the moil. The inertial body being ported so that working air is supplied to a front face of the piston assembly to urge it to a coked position away from the moil and whereby the accumulator is in its compressed state, and selectively operable porting for equalizing pressure between the front and rear faces of the piston, to continuously allow transfer of air between the faces while in operation.
Patent FI-20040139-A0 (FI)
Inventor: KOUKKARI EERO
IPC: H03G3/20
Filed: 2004-01-30
Abstract: An electronic circuit for adjusting a property of an input signal of a non-linear element is disclosed. A detector detects a strength of the input signal. An analog controller forms a control signal as a piecewise approximation of a non-linear dependency between the property and the strength of the input signal detected by the detector. An adjusting circuit adjusts the property of the input signal according to the control signal from a controller.
Patent IL-102085-A0 (IL)
Title: Tomographic gamma camera provided with a swivelling detector
IPC: A61B6/00
Filed: 1992-06-03
Abstract: The invention relates to medical imaging devices which use gamma rays. It consists, in a device in which a gamma camera is suspended from a framework (102) by a rotating base (103), of an arm (205) and two axles (104, 207) allowing two rotational movements (X, Y) of the detector head (101) of the gamma camera with respect to the rotating base, and in providing a stirrup (209) connected to the arm by a third axle (208) allowing a third rotational movement (Z) of this gamma camera. It makes it possible to facilitate the relative positioning of the gamma camera and of the patient being examined. 
<IMAGE>
Patent IL-109139-A0 (IL)
Title: Diamine salts of clavulanic acid, their preparation and pharmaceutical compositions containing them
IPC: C07D503/18
Filed: 1994-03-25
Abstract: New diamine salts of clavulanic acid, pharmaceutical compositions comprising the same, and a new process using these diamine salts in the preparation of clavulanic acid and salts and esters thereof have been provided.
Patent IL-110281-A0 (IL)
Title: A process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process
IPC: B29C35/08
Filed: 1994-07-11
Abstract: A measured-out quantity of a material which can be crosslinked by exposure to a suitable form of energy, in particular UV light (3), is introduced into a two-part mould (1), the cavity (15) of which defines the shape of a moulded part (CL) to be produced. The two mould halves (11, 12) are kept at a small distance from each other, so that there is formed between them a thin annular gap (16), which is in connection with the mould cavity (15) and through which excess material can escape. The crosslinkage is initiated by exposure to the chosen form of energy, exposure being spatially limited to the cavity (15) by suitable masking (21), so that material outside the mould cavity is not crosslinked. In this way, moulded parts which do not require secondary finishing are obtained, and the mould is reusable. The process is suitable in particular, but not exclusively, for the production of contact lenses. <IMAGE>
Patent IL-114337-A0 (IL)
Title: Aramide flat structures and process for forming contours
IPC: F41H5/04
Filed: 1995-06-26
Abstract: PCT No. PCT/EP95/02116 Sec. 371 Date Jan. 30, 1997 Sec. 102(e) Date Jan. 30, 1997 PCT Filed Jun. 3, 1995 PCT Pub. No. WO96/01406 PCT Pub. Date Jan. 18, 1996In a process for forming contours in aramide flat structures, in particular textile flat structures made from aramide fibers, contouring is performed by molding in a temperature range of 180-300 DEG  C. and a press pressure range of 4-8 bar (400-800 kPa). The flat structures contoured by molding are suited in particular for the manufacture of antiballistic women's protective clothing as well as of antiballistic helmets. The effectiveness against penetration of bullets and splinters is not affected by the molding process.
Patent IL-123409-A0 (IL)
Title: Imaging system and method
IPC: H04N5/32
Filed: 1996-08-08
Abstract: An imaging support for supporting imaging devices in respective positions to define an imaging surface is arranged to permit the imaging devices to be removably mounted on the support in a non-destructive, removable manner. In one embodiment the removable mounting is achieved by providing a source of reduced air pressure behind the imaging devices on the imaging support to suck the imaging devices onto the imaging support so that the imaging devices are accurately located on the support in a removable, non-destructive manner. The imaging devices are removable without damage to the device to be removed, the surrounding devices or the support. Defective devices can readily and quickly be replaced. Correctly functioning imaging devices can easily be removed and re-used on the same or a different imaging support.
Patent IL-136591-A0 (IL)
Title: Nasal solutions
IPC: A61P27/16
Filed: 1999-01-28
Abstract: The invention relates to liquid phamaceutical compositions adapted to nasal administration. The liquid nasal formulations of the invention are characterized inter alia by having excellent and prolonged moisturizing properties.
Patent IL-138005-A0 (IL)
Title: Transdermal therapeutic system (tts) containing pergolide
IPC: A61K47/34
Filed: 1999-05-12
Abstract: The invention relates to a transdermal therapeutic system (TTS) for the transcutaneous administration of pergolide over several days and to a method for its manufacture without using solvents. The TTS contains a matrix mass, containing pergolide and taking the form of a layer, which contains a (meth)acrylate copolymer containing ammonio groups or a mixture of a (meth)acrylate copolymer containing amino groups and a (meth)acrylate polymer containing carboxyl groups, 10-50% by weight propylene glycol and up to 5% by weight pergolide.
Patent IL-144822-A0 (IL)
Title: Dispersion of refrigerant materials
IPC: C09K5/06
Filed: 2000-02-24
Abstract: Portable refrigeration devices (1) including methods for preparing evaporator chambers (10) for use in such devices, and the evaporator chambers (10) prepared in this way. The methods relate to the dispersion of refrigerant for the maximization of efficiency of vaporization of refrigerant vapor from the evaporator chamber (10) of such refrigeration devices (1).
Patent IL-148082-A0 (IL)
Title: Process forproducing carotenoid pigments
IPC: C12P23/00
Filed: 2001-06-08
Abstract: The present invention provides a method for changing production ratios of carotenoid compounds in a process of microbiological production of a plurality of carotenoid compounds. By controlling the concentration of dissolved oxygen in the culture during cultivation, production ratios of carotenoid compounds such as astaxanthin, adonixanthin,  beta -carotene, echinenone, canthaxanthin, zeaxanthin, beta -cryptoxanthin, 3-hydroxyechinenone, asteroidenone and adonirubin, are changed.
Patent IL-156523-A0 (IL)
Title: System and method for electrically induced breakdown of nanostructures
IPC: H01L29/06
Filed: 2001-12-21
Abstract: A method is provided for forming a device. The method provides a substrate, and provides a plurality of nanotubes in contact with the substrate. The method comprises depositing metal contacts on the substrate, wherein the metal contacts are in contact with a portion of at least one nanotube. The method further comprises selectively breaking the at least one nanotube using an electrical current, removing the metal contacts, cleaning a remaining nanotube, and depositing a first metal contact in contact with a first end of the nanotube and a second metal contact in contact with a second end of the nanotube.
Patent IL-183370-A0 (IL)
Title: Monoclonal antibody production by ebv transformation of b cells
IPC: C07K16/10
Filed: 2007-05-21
Abstract: A method for producing a clone of an immortalised human B memory lymphocytes, comprising the step of transforming human B memory lymphocytes using Epstein Barr Virus (EBV) in the presence of a polyclonal B cell activator. The method is particularly useful in a method for producing a clone of an immortalised human B memory lymphocytes capable of producing a human monoclonal antibody with a desired antigen specificity, comprising the steps of : (i) selecting and isolating a human memory B lymphocyte subpopulation; (ii) transforming the subpopulation with Epstein Barr Virus (EBV) in the presence of a polyclonal B cell activator; (iii) screening the culture supernatant for antigen specificity; and (iv) isolating an immortalised human B memory lymphocyte clone capable of producing a human monoclonal antibody having the desired antigen specificity.
Patent IL-198324-A0 (IL)
Title: Wind power installation and method for generation of electric power from ambient air in motion
IPC: B60L50/10
Filed: 2009-04-23
Abstract: The turbine has a flow channel (3) through which the surrounding air flows. A section (7) includes a constant cross section, into which the surrounding air is introduced, where an air acceleration device (39) is provided in the section (7). A section (7) is designed in the form of a venture nozzle, and a section (13) is designed in the form of a Laval nozzle (12). A section (15) includes another air acceleration device, which serves for production of air, which is guided into the flow channel. An independent claim is also included for a method for producing electricity from surrounding.